SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9546	Companies
188122	Keywords
120027	Articles
100492	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 12/17/2025 at 07:35, 11 hours 58 minutes ago

Sanofi Releases Q4 2025 Aide Mémoire

Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
BRIEF

published on 12/17/2025 at 07:35, 11 hours 58 minutes ago

Sanofi publishes the document "Q4 2025 Quick Reference Guide"

Financial Results Investors Sanofi Q4 2025 Modeling
PRESS RELEASE

published on 12/17/2025 at 07:30, 12 hours 3 minutes ago

Press release: Availability of the Q4 2025 Aide memoire
Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026

Sanofi Results Aide Mémoire Financial Modelling Q4 2025
BRIEF

published on 12/15/2025 at 07:10, 2 days 12 hours ago

Sanofi: PERSEUS study results on tolebrutinib disappointing

Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
BRIEF

published on 12/15/2025 at 07:10, 2 days 12 hours ago

Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS

Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
PRESS RELEASE

published on 12/15/2025 at 07:05, 2 days 12 hours ago

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed

Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
BRIEF

published on 12/15/2025 at 07:05, 2 days 12 hours ago

Sanofi's Tolebrutinib Regulatory Submission Delayed

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
PRESS RELEASE

published on 12/15/2025 at 07:00, 2 days 12 hours ago

Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi anticipates a delay in tolebrutinib regulatory decision for nrSPMS, with ongoing discussions with the FDA. An expanded access protocol has been submitted for eligible patients

FDA Sanofi Tolebrutinib Regulatory Submission NrSPMS
BRIEF

published on 12/11/2025 at 07:05, 6 days 12 hours ago

Sanofi obtains approval in China for Qfitlia and Cablivi

China Sanofi Rare Diseases Qfitlia Cablivi
BRIEF

published on 12/11/2025 at 07:05, 6 days 12 hours ago

Sanofi's Breakthrough in China with Qfitlia and Cablivi Approvals

Sanofi Rare Diseases Qfitlia Cablivi China Approvals

Accesswire

Published on 12/17/2025 at 15:00, 4 hours 33 minutes ago

BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 5 hours 33 minutes ago

UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/17/2025 at 13:35, 5 hours 58 minutes ago

Silver X Mining Announces Grant of Incentive Stock Options and Restricted Share Units
Published on 12/17/2025 at 13:15, 6 hours 18 minutes ago

Aclara Wins UN Global Compact Award for Its Contribution to Local Employment and Suppliers
Published on 12/17/2025 at 13:00, 6 hours 33 minutes ago

Gold Terra Provides a Summary of 2025 Achievements and 2026 Plan

View all ACCESSWIRE

EQS Group

Published on 12/17/2025 at 19:10, 22 minutes ago

Holand Automotive Group Announces the sale of Ferrari Rancho Mirage to Lapis Automotive Group
Published on 12/17/2025 at 18:39, 54 minutes ago

EQS-Adhoc: centrotherm international AG: Centrotherm AcquiCo AG submits request for the squeeze-out of minority shareholders of centrotherm international AG
Published on 12/17/2025 at 18:10, 1 hour 22 minutes ago

POS-Transaction in Own Shares
Published on 12/17/2025 at 18:05, 1 hour 27 minutes ago

Valour Inc. Launches Constant Leveraged Bitcoin and Ethereum ETPs on Spotlight Stock Market
Published on 12/17/2025 at 17:32, 2 hours ago

EQS-Adhoc: Raiffeisen Bank International AG: Michael Höllerer will succeed Johann Strobl as CEO of RBI on 1 July 2026

Les Echos

Published on 12/17/2025 at 19:30, 3 minutes ago

Change in the composition of the Board
Published on 12/17/2025 at 18:00, 1 hour 33 minutes ago

Outstanding Shares and Voting Rights Statement at 30 November 2025
Published on 12/17/2025 at 17:51, 1 hour 42 minutes ago

Mr.Bricolage: Completion of the simplification of the Mr.Bricolage Group’s shareholding structure
Published on 12/17/2025 at 17:50, 1 hour 43 minutes ago

The Council of Paris approves the selection of Dalkia/Eiffage/RATP Solutions Ville consortium for Paris district heating network concession renewal.
Published on 12/17/2025 at 17:45, 1 hour 48 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025

View all LES ECHOS COMFI WIRE